Response to interleukin-17

pathway activity — cross-omics
GO:0097396Cross-omicsRNA → PROTEIN-MSPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, RNA activity of the Response to interleukin-17 pathway is significantly associated with the protein abundance of multiple proteins, with the GBM cohort showing a particularly strong set of associations.

The most reproducible pathway-associated proteins across cancer lineages are AMPD3, FMNL1, and MYO1G, each associated with the pathway in up to 9 cancer types. Since the analysis shows associations rather than directional relationships, both pathway-to-partner and partner-to-pathway views are reported.

Each partner is linked to its corresponding Q-omics profile. The scatter plot shows the strongest association, Response to interleukin-17 activity versus AMPD3 in GBM (Pearson r = 0.32).

Pathway-associated proteins by consensus

Ranked by combined sampling and lineage consensus. X-score (pathway→partner) and Y-score (partner→pathway) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
GBMAMPD3 →+0.696+0.116<.001<.00139
GBMFMNL1 →+0.521+0.111<.001<.00139
CCRCCMYO1G →+0.559+0.125<.001<.00139
GBMNCF2 →+0.538+0.091<.001<.00139
GBMICAM1 →+0.548+0.083<.001<.00139
GBMARHGAP30 →+0.496+0.089<.001<.00139
Each partner links to its Q-omics profile. Showing the 6 strongest associations by consensus.

GO:0097396 vs AMPD3 — GBM

Per-sample scatter of Response to interleukin-17 activity vs AMPD3 in GBM.

Explore this scatter interactively →

Exploration